![Peter Wolfe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Wolfe
Directeur Financier/CFO chez
ZYVERSA THERAPEUTICS, INC.
Fortune : 26 $ au 31/05/2026
Profil
Peter Wolfe is currently Chief Financial Officer & Secretary at ZyVersa Therapeutics, Inc., a position held since 2022.
Education history includes an MBA from the University of Pittsburgh and an undergraduate degree from the University of Miami.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/07/2025 | 127 ( 0% ) | 26 $ | 31/05/2026 |
Postes actifs de Peter Wolfe
| Sociétés | Poste | Début |
|---|---|---|
| ZYVERSA THERAPEUTICS, INC. | Directeur Financier/CFO | 12/12/2022 |
Formation de Peter Wolfe
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ZyVersa Therapeutics, Inc.
 ZyVersa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops product candidates in the areas of renal and inflammatory diseases | Health Technology |
